PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAzzalure
Azzalure
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1223 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Muscle spasticityD009128375924
Overactive urinary bladderD053201EFO_1000781N32.814103824
Migraine disordersD008881EFO_0003821G4357719
Urinary incontinenceD014549R321264518
EnuresisD004775R321164517
StrokeD020521EFO_0000712I63.91352314
TorticollisD014103F45.814611
DystoniaD004421212610
FaciesD0190661247
Dystonic disordersD020821G2421147
Show 24 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SyndromeD0135772449
HeadacheD006261R511449
Cerebral palsyD002547G80155
Somatoform disordersD013001F45224
Pelvic painD0176992114
Myofascial pain syndromesD009209EFO_1001054112
FibromyalgiaD005356EFO_0005687M79.1112
ProstatitisD011472EFO_0003830N41112
ArthritisD001168EFO_0005856M05-M14112
Temporomandibular joint disordersD013705M26.611
Show 22 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeuralgiaD009437EFO_0009430213
Prostatic hyperplasiaD011470EFO_0000284N40133
HyperplasiaD006965EFO_0000536133
Knee osteoarthritisD020370EFO_0004616M1722
HypertrophyD006984EFO_000246022
OsteoarthritisD010003EFO_0002506M15-M19122
CicatrixD002921L90.522
Magnetic resonance imagingD00827911
TherapeuticsD01381211
Joint diseasesD007592M12.911
Show 16 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Complex regional pain syndromesD020918EFO_100199811
Reflex sympathetic dystrophyD012019EFO_1001147G90.511
VaginismusD052065N94.211
PsoriasisD011565EFO_0000676L4011
Chronic painD05935011
Stress urinary incontinenceD01455011
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Herpes simplexD006561B0011
Herpes labialisD006560EFO_1001347B00.111
StrabismusD013285H50.211
Diabetes mellitusD003920EFO_0000400E08-E1311
Neck painD019547M54.211
Back painD001416M5411
ClubfootD003025Q66.011
Equinus deformityD00486311
TalipesD000070558Q66.111
DysphoniaD055154R49.011
Show 5 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
141 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use